NANETS congratulates NCIS recipient Katherine VanLoon, MD, MPH. She plans to use the robust database available from the NCCN’s multi-institutional Neuroendocrine Tumor Outcomes Project to report recurrence rates, time to tumor recurrence, and survival for patients with gastroenteropancreatic neuroendocrine tumors (NETs) who undergo surgical resection with curative intent. 

Because NCCN guidelines for surveillance imaging following resection are vague and reflect lack of standardization, I will describe the surveillance practices of the member institutions for patients who undergo complete surg

ical resection of gastroenteropancreatic NETs. This analysis will attempt to identify patient subgroups at particularly high risk of recurrence following surgical resection of gastroenteropancreatic NETs.